Abstract | AIM: To evaluate the outcomes of treating deep recalcitrant fungal keratitis with intrastromal voriconazole injection. METHODS: Twenty-five patients with culture proven fungal keratitis, not responding to a combination of topical 5% natamycin and 1% voriconazole were treated with intrastromal voriconazole (50 µg/0.1 mL) injected in five divided doses around the infiltrate to form a depot of the drug around the circumference of the lesion. RESULTS: The mean age of the patients was 52.52±12.21 years and mean time to presentation was 17.12±13.75 days from the onset of symptoms. The mean area of the infiltrate was 30.41±17.2 mm(2), hypopyon was present in 88% and all cases had infiltrates that extended beyond the mid-stromal level. Intrastromal voriconazole helped to resolve the infection in 18 (72%) patients and about 15% of these needed more than one injection. Smaller ulcers responded better to treatment. Fusarium spp were responsible for six of the seven cases that failed treatment. CONCLUSIONS: Targeted delivery of voriconazole by intrastromal injection (50 µg/0.1 mL) is a safe and effective way to treat deep recalcitrant fungal keratitis, though some may need repeated injections. Fusarium keratitis may show suboptimal response but this needs further study.
|
Authors | Ganapathy Kalaiselvi, Sivananda Narayana, Tiruvengada Krishnan, Sabyasachi Sengupta |
Journal | The British journal of ophthalmology
(Br J Ophthalmol)
Vol. 99
Issue 2
Pg. 195-8
(Feb 2015)
ISSN: 1468-2079 [Electronic] England |
PMID | 25185253
(Publication Type: Journal Article)
|
Copyright | Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. |
Chemical References |
- Antifungal Agents
- Voriconazole
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Antifungal Agents
(therapeutic use)
- Corneal Stroma
(drug effects, microbiology)
- Corneal Ulcer
(drug therapy, microbiology)
- Eye Infections, Fungal
(drug therapy, microbiology)
- Female
- Follow-Up Studies
- Fungi
(isolation & purification)
- Humans
- Injections, Intraocular
- Male
- Middle Aged
- Treatment Outcome
- Visual Acuity
(physiology)
- Voriconazole
(therapeutic use)
- Young Adult
|